Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide in lactating mothers for neonatal jaundice prevention and maternal prolactin
IRCT2016101710324N34Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metoclopramide in jaundice, sponsored by Tabriz University of Medical Sciences. Primary endpoints: Newborn bilirubin and Maternal prolactin. Started Jan 2017; status: completed.
02
Drugs
metoclopramide
03
Conditions
jaundice
Beyond the preview
Go deeper on IRCT2016101710324N34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016101710324N34.